Additionally, mutations in PIK3CA, AKT1, and PTEN have been observed in aggressive and recurrent thyroid tumors [22–24], indicating that the PI3K/Akt pathway plays a pivotal role in the initiation of thyroid tumors, second only to the MAPK signaling pathway. The gene discussed is AKT1; the disease is thyroid tumor.